Immunodiagnostic Analyzer & Reagents

Awarded Award Notice Posted

Solicitation number
W81K00-20-P-0098
Agency
Medical Command Department of the Army, Department of Defense
Awarded
to Phadia US Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
W81K00-20-P-0098 Federal contract award
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Place of performance
El Paso TX 79920 USA

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of the Army Medical Command published an Award Notice on April 1, 2020 for a sole source bridge contract awarded to Phadia USA, Inc. for $316,475.78. The contract provides immunodiagnostic analyzers and reagents/consumables for various allergen and asthma assays to support testing and diagnosis at William Beaumont Army Medical Center, and has a period of performance from April 1 to September 30, 2020 utilizing fiscal year 2020 funding.

Notice text

Sole Source Award in accordance with attached J&A.

Awarded contract W81K00-20-P-0098 to Phadia USA, Inc for 314675.78 on 2020-03-31.

Attachments

Files attached to this notice, newest first
File Type Posted
Phadia Bridge Justification and Approval_Redacted.pdf PDF

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Immunodiagnostic Analyzer & Reagents This notice · Award Award Notice
Immunodiagnostic Analyzer & Reagents Latest special notice Special Notice

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity